Ramírez-Giraldo Camilo, Van-Londoño Isabella, Pesce Antonio
Department of Surgery, Hospital Universitario Mayor - Méderi, Bogotá, Colombia.
Universidad del Rosario, Bogotá, Colombia.
World J Emerg Surg. 2025 Jan 10;20(1):4. doi: 10.1186/s13017-025-00574-x.
Empirical antibiotic therapy is often initiated during the hospital stay while awaiting laparoscopic cholecystectomy. This approach is generally justified in patients with moderate (Tokyo II) and severe (Tokyo III) acute cholecystitis, where organ dysfunction occurs as a result of the inflammatory or infectious process. However, there is no clear consensus regarding the use of antibiotics in patients with mild (Tokyo I) cholecystitis. This study aimed to evaluate the impact of preoperative antibiotic use on outcomes in patients with acute cholecystitis.
A systematic review of PubMed, Embase and Cochrane was conducted following the PRISMA methodology. Studies were eligible for inclusion if they were randomized controlled trials or non-randomized comparative studies evaluating the use or non-use of preoperative antibiotics in patients with acute cholecystitis. Eligible studies were required to provide at least one of the following datasets: postoperative complication rate, postoperative infectious complication rate, or positive culture rate. The synthesis reports were prepared using the Synthesis Without Meta-analysis (SWiM) framework.
A total of 622 articles were initially identified, of which 2 met the inclusion criteria. These two articles included 331 patients. They reported higher rates of postoperative complications and bacterobilia in the group that received preoperative antibiotics; however, the differences were not statistically significant (p > 0.05).
Based on current evidence, no recommendation can be made regarding the therapeutic use of antibiotics in mild acute cholecystitis while awaiting laparoscopic cholecystectomy.
在等待腹腔镜胆囊切除术期间,通常会在住院期间开始经验性抗生素治疗。对于中度(东京II型)和重度(东京III型)急性胆囊炎患者,这种方法通常是合理的,因为炎症或感染过程会导致器官功能障碍。然而,对于轻度(东京I型)胆囊炎患者使用抗生素尚无明确共识。本研究旨在评估术前使用抗生素对急性胆囊炎患者预后的影响。
按照PRISMA方法对PubMed、Embase和Cochrane进行系统评价。如果研究是评估急性胆囊炎患者术前使用或不使用抗生素的随机对照试验或非随机对照研究,则有资格纳入。符合条件的研究需要提供以下至少一个数据集:术后并发症发生率、术后感染性并发症发生率或阳性培养率。使用无荟萃分析的综合(SWiM)框架编写综合报告。
最初共识别出622篇文章,其中2篇符合纳入标准。这两篇文章共纳入331例患者。他们报告接受术前抗生素治疗的组术后并发症和胆瘘发生率较高;然而,差异无统计学意义(p>0.05)。
根据目前的证据,在等待腹腔镜胆囊切除术期间,对于轻度急性胆囊炎患者使用抗生素进行治疗尚无推荐意见。